BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -4.39%5.24B | 3.76%24.23B | 7.91%17.11B | 10.95%11.05B | 12.37%5.49B | 16.78%23.35B | 15.52%15.86B | 18.11%9.96B | 15.44%4.88B | 13.57%20B |
Operating revenue | -4.39%5.24B | 3.76%24.23B | 7.91%17.11B | 10.95%11.05B | 12.37%5.49B | 16.78%23.35B | 15.52%15.86B | 18.11%9.96B | 15.44%4.88B | 13.57%20B |
Other operating revenue | ---- | 18.38%57.59M | ---- | 157.96%22.27M | ---- | 383.92%48.65M | ---- | 298.55%8.63M | ---- | 89.03%10.05M |
Total operating cost | -3.40%4.88B | 5.02%22.61B | 9.28%15.92B | 11.49%10.3B | 12.03%5.06B | 16.44%21.53B | 15.17%14.57B | 18.21%9.24B | 15.92%4.51B | 16.13%18.49B |
Operating cost | -4.97%4.16B | 3.71%19.65B | 8.74%13.73B | 11.10%8.91B | 11.69%4.38B | 17.51%18.95B | 15.90%12.63B | 19.57%8.02B | 18.43%3.92B | 19.25%16.12B |
Operating tax surcharges | -0.18%20.92M | -1.17%95.65M | 2.22%65.09M | 13.63%40.2M | 19.61%20.96M | 28.03%96.77M | 26.18%63.68M | 10.66%35.38M | -1.19%17.52M | 13.65%75.59M |
Operating expense | 5.23%427.46M | 12.11%1.74B | 14.65%1.29B | 13.75%811.18M | 19.24%406.2M | 14.14%1.55B | 9.17%1.13B | 10.63%713.13M | -0.34%340.65M | -2.82%1.36B |
Administration expense | 8.55%234.4M | 20.14%981.8M | 10.78%722.27M | 14.65%475.32M | 11.81%215.95M | 2.90%817.24M | 13.93%651.98M | 12.74%414.57M | 6.03%193.14M | 6.60%794.2M |
Financial expense | 29.92%-9.8M | 27.53%-39.62M | 36.30%-26.56M | 18.28%-24.7M | -150.38%-13.99M | -32.18%-54.68M | -18.49%-41.7M | -66.15%-30.23M | -48.48%-5.59M | -699.11%-41.37M |
-Interest expense (Financial expense) | -2.89%6.71M | 9.34%27.33M | 8.72%20.11M | 8.73%13.29M | 17.30%6.91M | 69.35%25M | 3.88%18.49M | 4.55%12.22M | 1.29%5.89M | -35.40%14.76M |
-Interest Income (Financial expense) | 37.00%-14.06M | 15.94%-64.18M | 8.57%-49.54M | -5.01%-36.96M | -32.40%-22.32M | -96.07%-76.35M | -54.51%-54.19M | -51.99%-35.2M | -47.79%-16.86M | -22.45%-38.94M |
Research and development | 3.96%50.21M | 6.55%189.15M | -1.55%142.23M | 3.34%92.44M | 2.57%48.3M | -3.28%177.53M | 4.64%144.47M | 5.09%89.46M | 4.31%47.09M | -2.76%183.55M |
Credit Impairment Loss | ---- | -30.14%-28.41M | -76.55%-27.95M | -76.55%-27.95M | ---- | -403.17%-21.83M | -206.01%-15.83M | -206.01%-15.83M | ---- | 202.67%7.2M |
Asset Impairment Loss | ---- | -209.66%-12.88M | ---- | ---- | ---- | 162.92%11.74M | ---- | ---- | ---- | -9.22%-18.67M |
Other net revenue | -18.77%61.4M | 28.08%145.13M | 64.60%132.06M | 63.21%69.83M | 76.60%75.58M | 6.30%113.32M | -20.71%80.23M | -7.26%42.78M | 109.27%42.8M | 6.95%106.6M |
Fair value change income | -23.24%9.66M | 99.93%54.36M | 62.35%37.28M | 54.91%24.54M | 62.90%12.58M | -14.61%27.19M | -10.45%22.96M | 5.85%15.84M | 0.82%7.72M | -17.58%31.84M |
Invest income | 961.13%7.54M | 90.72%-364.76K | 63.79%-587.65K | -255.78%-1.45M | -172.25%-875.75K | -1,527.39%-3.93M | -248.94%-1.62M | -26.18%929.61K | -12.95%1.21M | -95.62%275.5K |
-Including: Investment income associates | 94.74%-109.88K | 36.07%-3.96M | 5.82%-3.45M | -102.02%-3.26M | -1,580.92%-2.09M | -257.99%-6.2M | -404.22%-3.66M | -292.78%-1.61M | 55.32%-124.17K | -226.17%-1.73M |
Asset deal income | -156.43%-470.09K | -100.29%-10.28K | -98.95%21.94K | -68.39%473.78K | -9.84%833.02K | 11,448.90%3.59M | 8,208.45%2.1M | 160.70%1.5M | 1,770.34%923.94K | -100.52%-31.62K |
Other revenue | -29.15%44.66M | 37.16%132.44M | 69.76%123.29M | 83.94%74.2M | 91.40%63.04M | 12.30%96.56M | 21.95%72.63M | 180.13%40.34M | 190.28%32.93M | 18.19%85.98M |
Operating profit | -16.46%421.46M | -8.91%1.76B | -3.37%1.32B | 7.28%820.06M | 22.84%504.48M | 20.03%1.93B | 16.08%1.37B | 15.15%764.41M | 15.48%410.69M | -9.71%1.61B |
Add:Non operating Income | -74.76%1.89M | 30.95%78.13M | -74.77%10.54M | -67.61%9.06M | -57.10%7.49M | -12.95%59.66M | -11.97%41.77M | 2.77%27.98M | 110.94%17.45M | -30.18%68.54M |
Less:Non operating expense | 22.42%6.3M | 43.42%15.49M | 70.44%8.79M | 123.06%6.27M | 204.42%5.15M | -10.96%10.8M | 22.35%5.15M | 4.19%2.81M | 13.46%1.69M | -33.14%12.13M |
Total profit | -17.71%417.05M | -7.99%1.82B | -5.76%1.33B | 4.21%822.85M | 18.85%506.82M | 18.89%1.98B | 14.97%1.41B | 14.70%789.57M | 17.67%426.45M | -10.56%1.66B |
Less:Income tax cost | -14.87%87.55M | 9.24%366.52M | 8.09%258.05M | 15.62%153.93M | 69.76%102.84M | 8.41%335.53M | -2.59%238.74M | -5.36%133.14M | -20.66%60.58M | -5.58%309.52M |
Net profit | -18.44%329.5M | -11.51%1.45B | -8.59%1.07B | 1.90%668.92M | 10.42%403.98M | 21.29%1.64B | 19.37%1.17B | 19.86%656.44M | 27.90%365.87M | -11.62%1.36B |
Net profit from continuing operation | -18.44%329.5M | -11.51%1.45B | -8.59%1.07B | 1.90%668.92M | 10.42%403.98M | 21.29%1.64B | 19.37%1.17B | 19.86%656.44M | 27.90%365.87M | -11.62%1.36B |
Less:Minority Profit | -53.16%11.3M | -49.73%58.89M | -37.65%45.98M | -30.73%35.98M | -25.32%24.12M | 60.63%117.14M | 71.06%73.75M | 173.08%51.95M | 209.89%32.29M | 363.60%72.92M |
Net profit of parent company owners | -16.23%318.2M | -8.58%1.4B | -6.63%1.02B | 4.71%632.93M | 13.87%379.86M | 19.05%1.53B | 16.99%1.09B | 14.34%604.49M | 21.02%333.58M | -15.51%1.28B |
Earning per share | ||||||||||
Basic earning per share | -15.56%0.3472 | -8.54%1.5162 | -6.52%1.1058 | 4.95%0.6851 | 13.87%0.4112 | 19.48%1.6577 | 16.89%1.1829 | 14.29%0.6528 | 20.81%0.3611 | -15.66%1.3874 |
Diluted earning per share | -15.56%0.3472 | -8.54%1.5162 | -6.52%1.1058 | 4.95%0.6851 | 14.00%0.4112 | 19.48%1.6577 | 17.00%1.1829 | 14.45%0.6528 | 20.96%0.3607 | -15.53%1.3874 |
Other composite income | 201.56%8.56M | -1,289.74%-11.29M | 16.54%-4.99M | 24.63%-5.97M | 16.72%-8.43M | -76.13%-812.73K | 19.37%-5.98M | -41.18%-7.92M | -381.61%-10.12M | 79.85%-461.44K |
Other composite income of parent company owners | 216.41%8.86M | -1,543.32%-10.48M | 22.58%-3.97M | 23.16%-5.33M | 15.40%-7.61M | -11.47%-637.61K | 22.87%-5.13M | -36.89%-6.94M | -372.06%-9M | 69.53%-572.01K |
Other composite income of minority owners | 63.80%-297.05K | -366.50%-816.94K | -20.14%-1.02M | 35.06%-632.51K | 27.26%-820.58K | -258.37%-175.12K | -11.20%-846.15K | -81.81%-974.02K | -491.09%-1.13M | 126.78%110.57K |
Total composite income | -14.53%338.06M | -12.15%1.44B | -8.55%1.06B | 2.22%662.95M | 11.19%395.55M | 21.27%1.64B | 19.66%1.16B | 19.63%648.52M | 22.82%355.74M | -11.52%1.35B |
Total composite income of parent company owners | -12.14%327.06M | -9.23%1.39B | -6.55%1.02B | 5.03%627.6M | 14.69%372.25M | 19.06%1.53B | 17.27%1.09B | 14.12%597.55M | 16.36%324.58M | -15.44%1.28B |
Total composite income of minority owners | -52.79%11M | -50.35%58.07M | -38.32%44.97M | -30.65%35.35M | -25.25%23.3M | 60.15%116.96M | 72.14%72.9M | 175.73%50.97M | 191.01%31.16M | 376.82%73.03M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.